✉ Email this page to a colleague
« Back to Dashboard
Potassium chlorideis the generic ingredient in forty-four branded drugs marketed by Savage Labs, Upsher Smith Labs, Nesher Pharms, Actavis Labs Fl Inc, Adare Pharms Inc, Amneal Pharms, Anchen Pharms, Chartwell Molecular, Glenmark Pharms Ltd, Granules, Lupin Ltd, Novel Labs Inc, Padagis Us, Prinston Inc, Strides Pharma, Teva, Tris Pharma Inc, Zydus Pharms, Amneal, Belcher, Epic Pharma Llc, Novitium Pharma, Pharma Res Software, Rubicon, Kv Pharm, Abraxis Pharm, Akorn, B Braun, Baxter Hlthcare, Fresenius Kabi Usa, Gd Searle Llc, Hospira, Intl Medication, Lilly, Luitpold, Miles, Pharma Serve Ny, Watson Labs, Nexus, Icu Medical Inc, Apotex, Genus Lifesciences, Guardian Drug, Pharm Assoc, Saptalis Pharms, Wes Pharma Inc, Future Pak, Abbvie, Apothecon, Ascent Pharms Inc, Aurobindo Pharma, Aurobindo Pharma Ltd, Breckenridge, Copley Pharm, Guangzhou Novaken, Mylan, Schering, Sigmapharm Labs Llc, Twi Pharms, Yichang Humanwell, and Novartis, and is included in one hundred and twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.
There are twenty-four drug master file entries for potassium chloride. Ninety-three suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for potassium chloride
|Drug Master File Entries:||24|
|Finished Product Suppliers / Packagers:||93|
|Raw Ingredient (Bulk) Api Vendors:||313|
|Drug Prices:||Drug price trends for potassium chloride|
|Drug Sales Revenues:||Drug sales revenues for potassium chloride|
|What excipients (inactive ingredients) are in potassium chloride?||potassium chloride excipients list|
|DailyMed Link:||potassium chloride at DailyMed|
Generic filers with tentative approvals for POTASSIUM CHLORIDE
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for potassium chloride
|Drug Class||Osmotic Laxative|
|Mechanism of Action||Osmotic Activity|
|Physiological Effect||Increased Large Intestinal Motility|
Inhibition Large Intestine Fluid/Electrolyte Absorption
Anatomical Therapeutic Chemical (ATC) Classes for potassium chloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Hospira||POTASSIUM CHLORIDE||potassium chloride||INJECTABLE;INJECTION||080205-005||Approved Prior to Jan 1, 1982||DISCN||No||No||⤷ Try a Trial||⤷ Try a Trial||⤷ Try a Trial|
|Padagis Us||POTASSIUM CHLORIDE||potassium chloride||TABLET, EXTENDED RELEASE;ORAL||205993-002||Nov 5, 2015||AB2||RX||No||No||⤷ Try a Trial||⤷ Try a Trial||⤷ Try a Trial|
|Upsher Smith Labs||KLOR-CON||potassium chloride||FOR SOLUTION;ORAL||209662-001||Oct 23, 2017||AA||RX||No||No||⤷ Try a Trial||⤷ Try a Trial||⤷ Try a Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Patent No.||Patent Expiration|
|Nesher Pharms||MICRO-K||potassium chloride||CAPSULE, EXTENDED RELEASE;ORAL||018238-001||Approved Prior to Jan 1, 1982||⤷ Try a Trial||⤷ Try a Trial|
|Schering||POTASSIUM CHLORIDE||potassium chloride||TABLET, EXTENDED RELEASE;ORAL||019439-002||Jun 13, 1986||⤷ Try a Trial||⤷ Try a Trial|
|Apothecon||KLOTRIX||potassium chloride||TABLET, EXTENDED RELEASE;ORAL||017850-001||Approved Prior to Jan 1, 1982||⤷ Try a Trial||⤷ Try a Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>Patent No.||>Patent Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.